189 related articles for article (PubMed ID: 22342800)
1. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice.
Olesen MV; Christiansen SH; Gøtzsche CR; Nikitidou L; Kokaia M; Woldbye DP
J Neurosci Res; 2012 Feb; 90(2):498-507. PubMed ID: 21971867
[TBL] [Abstract][Full Text] [Related]
3. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.
Christiansen SH; Olesen MV; Gøtzsche CR; Woldbye DP
Neuropeptides; 2014 Dec; 48(6):335-44. PubMed ID: 25267070
[TBL] [Abstract][Full Text] [Related]
5. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
7. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
8. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
10. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
Woldbye DP; Angehagen M; Gøtzsche CR; Elbrønd-Bek H; Sørensen AT; Christiansen SH; Olesen MV; Nikitidou L; Hansen TV; Kanter-Schlifke I; Kokaia M
Brain; 2010 Sep; 133(9):2778-88. PubMed ID: 20688813
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
[TBL] [Abstract][Full Text] [Related]
13. Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice.
Lin EJ; Lin S; Aljanova A; During MJ; Herzog H
Eur Neuropsychopharmacol; 2010 Mar; 20(3):164-75. PubMed ID: 19781916
[TBL] [Abstract][Full Text] [Related]
14. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
16. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.
Christensen DZ; Olesen MV; Kristiansen H; Mikkelsen JD; Woldbye DP
J Neurosci Res; 2006 Nov; 84(6):1282-91. PubMed ID: 16941487
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
19. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
20. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
